How much more reinforced they will be, when they come to Greece
Tuesday 16 August 2022, 00:00
Autumn is approaching and everyone’s interest is focused on updated vaccines, exactly where they are coming and how much they will protect against transmission of infection and serious intellect compared to existing ones.
The bar of expectations has been raised high, but the exact delivery schedule of the new formulations remains fluid, with information from the Ministry of Health talking about two doses, after October. The optimists set the milestone after the beginning of October, while the more cautious postpone it for December.
Health Minister Thanos Pleuris clarifies that the two companies Moderna and Pfizer that manufacture vaccines with mRNA technology have filed their files and are in approval procedures with the American Food and Drug Administration (FDA). Moderna is conducting clinical trials for its vaccine against Omicron 1 and 2, while Pfizer is conducting clinical trials for its vaccine against Omicron 4 and 5. Their approval in the US will be fast-tracked by the FDA , when the vaccines will also become available on the other side of the Atlantic for American citizens in early October.
For his part, EKPA pulmonology professor Thodoris Vasilakopoulos points out that the updated vaccines are more strengthened and will protect three times more than the existing ones, as they will include the original strain that the previous ones had, but also the new strains, i.e. the “mother” . Omicron, together with the sub-variants Omicron 2, Omicron 4 and Omicron 5″.
The updated vaccines since they are in smaller supply will be given primarily to the healthy people and we will wait to see the recommendations of the national vaccination committee on how much only special groups should be vaccinated or again the whole population.
Since the vaccines will be partial, it is logical that the vulnerable should have priority, as through the booster doses of the existing vaccines, the titer of neutralizing antibodies comes transiently for about 3 months.
The main goal with the release of the updated vaccines is to reduce the spread of the coronavirus in the community to reduce both cases and the chance that someone will get infected. Of course, scientists know that until the updated vaccines become available on the old continent, it is likely that new mutations will emerge by then that will not be covered by the new vaccinations.
In the future vaccines will be much more effective and much longer lasting so that they can be given annually in the influenza management model. However, as EKPA pulmonology professor Thodoris Vasilakopoulos explains, multi-potent barriers are also expected from the autumn, which will offer protection against the sources of mutations and nasal vaccines (inhaled) which are very easily administered to everyone and will fight the virus in the nasal mucus. before it achieves its introduction into the organization.